Evidence map›Paper›PMID 29138553›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2017

The protective effect of PRMT6 overexpression on cigarette smoke extract-induced murine emphysema model.

Xue He, Tiao Li, Naixin Kang, Huihui Zeng, Siying Ren, Dandan Zong, Jinhua Li, Shan Cai, Ping Chen, Yan Chen

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Current views in chronic obstructive pulmonary disease pathogenesis and management.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Nucleosides isolated fromInternational journal of chronic obstructive pulmonary disease · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Xue HeDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Tiao LiDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Naixin KangDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Huihui ZengDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Siying RenDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Dandan ZongDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Jinhua LiDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Shan CaiDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Ping ChenDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Yan ChenDepartment of Respiratory Medicine, The Second Xiangya Hospital.
Central South University · CNState Key Laboratory of Respiratory Disease · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCigarette smoke exposure is the most common risk factor for emphysema, which is one of the major pathologies of COPD. Protein arginine methyltransferase 6 (PRMT6) is a nuclear enzyme that specially catalyzes dimethylation of R2 in histone H3 (H3R2me2a). H3R2me2a prevents trimethylation of H3K4 (H3K4me3), which is located in the transcription start sites of genes in mammalian genomes. We attempted to determine the expression of PRMT6 in human samples, and investigate whether the upregulation of PRMT6 expression can attenuate the development of cigarette smoke extract (CSE)-induced emphysema. Further experiments were performed to elucidate the molecular mechanisms involved. MATERIALS AND

methodsHuman lung tissues were obtained from patients undergoing pneumonectomy for benign pulmonary lesions. BALB/c mice were treated with lentiviral vectors intratracheally and injected with CSE three times. The protein expression of PRMT6, H3R2me2a, and H3K4me3 in human and mouse samples, as well as B-cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), and endothelial nitric oxide synthase (eNOS) in mice were detected in lung homogenates by Western blotting. The mRNA expression of cyclooxygenase-2, interleukin-6, Bcl-2, Bax, and eNOS in mice was measured by quantitative real-time polymerase chain reaction.

resultsThe expression of PRMT6 was significantly downregulated in the pulmonary parenchyma in smokers with COPD as well as in mice treated with CSE. Overexpression of PRMT6 was detected in the CSE + Lenti-PRMT6 group of mice, which reversed the expression of H3R2me2a and H3K4me3. Inflammation, apoptosis, and oxidative stress levels were severe in the CSE-treated emphysema mice compared with the control group, which was inhibited by the overexpression of PRMT6.

conclusionThe overexpression of PRMT6 might inhibit inflammation, apoptosis, and oxidative stress in CSE-induced emphysema mediated by H3R2me2a.

Indexed as

AdultAgedAnimalsApoptosisbcl-2-Associated X ProteinCigarette SmokingCyclooxygenase 2Disease Models, AnimalFemaleGenetic TherapyHumansInterleukin-6LungMaleMice, Inbred BALB CMiddle AgedBax protein, mousebcl-2-Associated X ProteinBcl2 protein, mouseCyclooxygenase 2Interleukin-6interleukin-6, mouseNitric Oxide Synthase Type IIINos3 protein, mouseNuclear ProteinsPRMT6 protein, humanProtein-Arginine N-MethyltransferasesProto-Oncogene Proteins c-bcl-2Ptgs2 protein, mouseSmokeapoptosiscigarette smoke extractCOPDinflammationoxidative stressPRMT6

Identifiers

PMID29138553
PMCPMC5680965
OpenAlexW2766500386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.